Compare Revvity Inc (RVTY) vs Vanguard Emerging Markets Stock Index Fund ETF (VWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Vanguard Emerging Markets Stock Index Fund ETF — how do they compare? Revvity Inc trades at $124.14 (market cap $13.82B), while Vanguard Emerging Markets Stock Index Fund ETF trades at $60.97. The key difference: Revvity Inc pays a 0.23% dividend while Vanguard Emerging Markets Stock Index Fund ETF pays none. Which is the better fit depends on your goals.
| RVTY | VWO | |
|---|---|---|
Market Cap | $13.82B | — |
Sector | Technology | — |
52-Week High | $130.94 | $61.44 |
52-Week Low | $82.26 | $52.42 |
Enterprise Value | $16.14B | — |
Dividend Yield | 0.23% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $127.08, down 2.41% on the day, with a bullish technical signal from moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, driven by diagnostics strength and improved cash flow. Recent news includes the acquisition of Human Cell Design and the launch of the SuperFlex prenatal screening system.
Outlook is positive with 52% analyst buy ratings and a $135.25 consensus price target, implying ~6% upside. Risks include a premium valuation (P/E 61.1) and execution of growth initiatives. Strong institutional interest, such as Bank of New York Mellon's $78.77 million investment, supports confidence in the stock's trajectory.
VWO trades at $61.245, down 0.32% today, with a bullish technical signal from moving averages and neutral oscillators. Recent news highlights strong institutional buying and emerging market ETF inflows, with a dividend scheduled for June 2026. The fund's low expense ratio of 0.06% and focus on developing economies attract cost-conscious investors seeking diversification.
Outlook remains positive due to institutional accumulation and emerging market growth potential, but risks include currency volatility and China's economic influence. The neutral RSI suggests limited near-term momentum, while ADX indicates a strengthening trend. Investors benefit from broad exposure but face geopolitical and concentration risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Vanguard Emerging Markets Stock Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Emerging Markets All Cap China A Inclusion Index. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the index in terms of key characteristics.
Read more on VWO →
